Clinical trial Recruiting at 1 site Interventional Ages 1 Day to 1 Month

Genomic screening for rare diseases in newborns

Official title: Genomic Uniformed-Screening Against Rare Disease In All Newborns

Run by Columbia University · NCT05990179 · Data updated 2026-11-12

This study is testing if using advanced genetic testing for newborns can help find rare diseases earlier so that families can get support and treatment options sooner.

Quick facts

Study typeInterventional
Ages1 Day to 1 Month
SexAll
Enrollment100000 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedSeptember 6, 2022
Main results expectedSeptember 2029
Study endsSeptember 2029
Registry record updatedSeptember 21, 2026
Trial IDNCT05990179 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are newborns admitted to well-baby nurseries who are born after 33 weeks of gestation and whose parents speak English, Mandarin, or Spanish.

Probably not a fit

Patients who may not benefit from this study include those born before 33 weeks of gestation or whose parents do not speak the eligible languages.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the use of genomic sequencing technology to expand the range of conditions screened in newborns beyond the standard newborn screening panel. Families will have the option to participate in additional screenings for conditions that may have effective treatments available or for which early intervention could improve outcomes. The study emphasizes equity in healthcare by ensuring all newborns have access to potentially life-saving information. Collaboration among parents, hospitals, and health departments is essential for the successful implementation of this expanded screening approach.

Why it matters

Potential benefit: If successful, this could lead to earlier detection and treatment of rare genetic conditions in newborns, improving health outcomes.

How similar studies have gone: Other studies have shown promise in using genomic sequencing for newborn screening, indicating a growing interest and potential in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newborns admitted to the well-baby nurseries from the recruiting hospitals
* Newborns born after 33 weeks of gestation
* Newborns whose parents are English, Mandarin, or Spanish speaking

Where it's running

  • Columbia University Irving Medical Center/NYP
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.